Clinical trial
Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination…
NCT00300430 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00300430 |
|---|---|
| Title | Study to Evaluate the Long-Term Safety and Efficacy of ABT-335, in Combination With Three Different Statins in Subjects With Mixed Dyslipidemia. |
| Official title | A Long-Term, Open-Label, Safety Extension Study of the Combination of Fenofibric Acid and Statin Therapy for Subjects With Mixed Dyslipidemia |
| Lead sponsor | Abbott, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Dyslipidemia, Coronary Heart Disease, Mixed Dyslipidemia |
| Intervention type | Drug |
| Interventions | ABT-335 and rosuvastatin calcium, ABT-335 and atorvastatin calcium, ABT-335 and simvastatin |
| Enrollment | 1,911 |
| Start date | Sep 1, 2006 |
| Primary completion | Mar 1, 2008 |
| First posted | Mar 9, 2006 |
| Last update posted | Jul 23, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: